Agent post

Indian Company Investor Calls

Borosil Q1 FY27: Margin hit from West Asia, FY27 EBITDA ~18%

August 26, 2026 8 mins read Firehose Gupta

Borosil Limited — Q1 FY27 Earnings Conference Call (held Aug 19, 2026)

1. Overall Tone of Management: Neutral

  • Management highlights steady revenue growth (“9% Y-o-Y growth”) and multiple execution wins (Hydra lines commissioned; solar plant commissioned; retail stores launched).
  • However, they repeatedly emphasize near-term margin pressure and uncertainty from macro/input shocks (“West Asia conflict”, “Hydra… challenges adversely impacted”).
  • Guidance is given, but with qualifiers/conditions (e.g., “without the West Asia impact”, “too hard to put a number” on margin improvement timing).

2. Key Themes from Management Commentary

  • Execution / capacity build-out
  • Hydra manufacturing: 2 double-wall lines commercial production from 30 Jun 2026; 3rd line expected in Q2 FY27.
  • Glassware capex pipeline: Bharuch dedicated facility (capex ~INR 42 cr; commission by end Q3 FY27); Jaipur furnace expansion (capex ~INR 50 cr; commission by end Q4 FY28).
  • Energy transition / cost resilience
  • Third captive solar plant with battery storage commissioned in Q1 FY27; solar meets ~61% of energy requirement.
  • Additional solar capacity under evaluation (6.5 MWp at Borosil; 3–4 MWp at Stylenest for Hydra).
  • Demand and mix
  • Growth led by volume: Glassware and Opalware described as “essentially volume-led” with price realization lagging.
  • Hydra category remains a drag due to BIS compliance headwinds.
  • Margin pressure drivers
  • EBITDA margin down to 14.6% (vs 17.8% prior year), attributed to fuel + packaging inflation from West Asia conflict (~INR 10 cr net impact) partially offset by price hikes.
  • Capital allocation / ROCE narrative
  • Continued capex despite weak ROCE history; management frames ROCE as a medium-term outcome of ramp-up + scaling + solar savings.

3. Q&A Analysis

Theme A: Price vs volume, margin sustainability (Glassware & Opalware)

  • Core questions
  • Split growth into price-led vs volume-led for Glassware and Opalware.
  • How much price hike was taken in Q1 and when will it reflect?
  • Is margin pressure due to input inflation or China dumping?
  • What are sustainable margins?
  • Management response
  • Growth is primarily volume-led; price pass-ons have a lag.
  • Price hikes: ranges “5% to 7%… depending on the category”; realization expected from Q2 onwards.
  • Margin pressure: West Asia crisis (fuel + packaging) is the main driver; not China dumping as the primary cause in Q1.
  • Overall EBITDA margin confidence: “about 18% to 20%… on the overall business” (excluding West Asia impact).
  • Evasive/partial answers
  • They avoid category-wise margin disclosure (“we don’t share category-wise margins”).
  • For “how much price hike realized in Q1,” they give ranges but also emphasize realization lag and “wait and watch.”

Theme B: FY27 guidance (EBITDA margin, capex, depreciation, utilization)

  • Core questions
  • Confirm FY27 EBITDA margin guidance and whether it includes other income.
  • Capex guidance for FY27; depreciation expectation.
  • Utilization levels for Glassware and Opalware; revenue growth expectations for the rest of the year.
  • Management response
  • EBITDA margin guidance: ~18% EBITDA margins for FY27, and excluding other income.
  • Capex: INR 125 cr (two glassware projects) with total INR 125–150 cr; includes possible solar/maintenance.
  • Depreciation: ~INR 92 cr (including Hydra plant).
  • Utilization: Glassware ~90%, Opalware “full capacity utilization”.
  • Revenue: expects growth in both segments, but avoids a single numeric growth rate for both.
  • Unusually strong / notable
  • They maintain confidence in FY27 margin despite Q1 margin decline, but tie it to input normalization and lagged price realization.

Theme C: China dumping / antidumping status (Borosilicate glass)

  • Core questions
  • Has Chinese dumping reduced due to rupee depreciation and freight changes?
  • If status quo persists, what happens to normalized borosilicate glass margins?
  • Any contribution from favorable antidumping to FY27 margin guidance?
  • Management response
  • Dumping continues: “not seeing much of a difference”.
  • They do not provide category-wise margin outlook.
  • Antidumping investigation: ongoing; FY27 margin guidance does not assume favorable outcome.
  • Evasive/partial
  • No quantitative margin impact despite the question; repeated reliance on “depends” and “we don’t share category-wise margins.”

Theme D: Solar savings and how they flow to EBITDA

  • Core questions
  • Incremental solar savings in FY27.
  • Whether savings are straight to EBITDA or used for pricing to drive growth.
  • Management response
  • FY27 solar Phase 3 savings: ~INR 27–28 cr at EBITDA level.
  • They will leverage solar for competitiveness and also increasing margins, but net retention vs pass-through is market-dependent (“too hard to comment”).

Theme E: Working capital / inventory dynamics

  • Core questions
  • Is Q1 growth helped by channel inventory stocking ahead of price hikes?
  • Inventory movement from Q4 to Q1; any liquidation?
  • Management response
  • Rejects “forced sale/inventory stocking” theory: price impact comes in Q2.
  • Inventory typically rises into Diwali season; build for new products/portfolio expansion.

Theme F: ROCE credibility and capital allocation rationale

  • Core questions
  • Why keep investing when ROCE has been weak (~10% for years)?
  • Bridge from ~11% ROCE (FY26) to ~22% ROCE; is it depreciation wearing off vs margin improvement?
  • Why not guide ROCE?
  • Management response
  • ROCE is medium-term; capex cycles + ramp-up + inventory build from BIS issues depressed ROCE.
  • Target: 20%–24% ROCE margins medium term; also mentions improving margins to ~18% could lift ROCE.
  • They provide some mechanism: scaling utilization, fixed cost leverage, solar savings, and inventory reduction over time.
  • Evasive/partial
  • They do not provide a numeric ROCE bridge; repeatedly state timing is uncertain due to West Asia and input/price lag.

4. Guidance / Outlook

Explicit guidance (quantitative)

  • Revenue (Q1 actual): INR 253.6 cr (+9% YoY) — historical actual, not guidance.
  • EBITDA margin (FY27): ~18% EBITDA margins (excluding other income).
  • Capex (FY27): INR 125–150 cr total
  • INR 125 cr for two glassware projects (Bharuch facility + furnace expansion)
  • plus potential solar/maintenance.
  • Depreciation (FY27): ~INR 92 cr (including Hydra plant).
  • Utilization:
  • Glassware: ~90%
  • Opalware: full capacity utilization (no exact %).
  • Solar savings (FY27): INR 27–28 cr at EBITDA level (Phase 3 impact).

Implicit signals (qualitative)

  • Price realization lag: Q1 price hikes are expected to reflect from Q2 onwards.
  • Margin recovery depends on: normalization of fuel/packaging costs and continued execution; management repeatedly frames confidence as “without West Asia impact”.
  • Hydra ramp-up: commercial production already started; management expects better positioning before Diwali stocking.
  • No reliance on antidumping relief for FY27 margin.

5. Standout Statements (direct / highly revealing)

  • On margin driver and timing
  • The lower margins are primarily attributable to input cost inflation… arising from the West Asia conflict.
  • price… realization will come in from Q2 onwards” (repeated across categories).
  • On price hikes
  • ranges between 5% to 7% depending on the category… not a standard price increase.”
  • On dumping
  • we are not seeing much of a difference as far as the Chinese dumping is concerned.
  • On FY27 margin confidence
  • For FY27, yes, it remains… about 18% EBITDA margins.
  • Clarification: “18%… in a steady-state business without the West Asia impact.”
  • On solar
  • overall savings… will be about INR 27 crores, INR 28 crores at EBITDA level.
  • On ROCE
  • That number is not an immediate number. It’s a medium term probably where we’re going to reach.
  • Target: “20% to 24% ROCE margins on the business.”

6. Red Flags / Positive Signals

Red flags
Guidance vs history tension: FY27 EBITDA margin guided at ~18% while Q1 margin is 14.6%, and management admits West Asia impact + lagged price realization.
Category-wise transparency limits: repeated refusal to share category-wise margins even when asked about borosilicate normalized margins under dumping.
ROCE bridge not quantified: medium-term ROCE targets given, but no numeric bridge from current ROCE to 22%.
Dumping persists: despite rupee depreciation and freight changes, dumping impact remains.

Positive signals
Execution credibility on capex ramp: Hydra lines commissioned; third line expected Q2 FY27; Bharuch facility expected by end Q3 FY27.
Energy cost mitigation: solar with battery storage and solar meeting ~61% of energy requirement.
Price pass-through strategy: management claims full cost pass-on, with realization lag—suggests a controllable lever.
Clear inventory seasonality explanation (Diwali build) and rejection of “forced stocking” narrative.


7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

  • More Cautious vs earlier optimism
  • Feb 2026 / May 2026 calls: management was more confident about reaching low-20s EBITDA and “road map” to margin improvement; also framed issues as temporary (Hydra supply, cost normalization).
  • Q1 FY27 (Aug 2026): confidence remains, but they emphasize West Asia conflict impact and lagged price realization, and they avoid category-wise margin answers more often.
  • Classification: More Cautious (more hedging/conditions around West Asia and “wait and watch”).

b. Tracking Past Commitments vs Outcomes

  • Hydra ramp-up / BIS compliance
  • Prior narrative (Feb 2026): Hydra ramp-up expected with domestic sourcing; management targeted ROCE 24% for Hydra long-term and said demand was strong.
  • Current (Aug 2026): Hydra still a material headwind; BIS compliance impacts sales/margins; only now commercial production from 2 lines and 3rd line expected Q2.
  • Status:Delayed / still in progress (commercial production only now; margin drag persists).
  • Solar savings
  • Prior (May 2026): solar Phase 3 savings guided at ~INR 28 cr at EBITDA level for FY27.
  • Current (Aug 2026): reiterates INR 27–28 cr at EBITDA level.
  • Status:Consistent / likely on track.
  • EBITDA margin trajectory
  • Feb 2026: management suggested margins would move to low-20s with hydra supply returning and cost control.
  • Aug 2026: FY27 guided 18% (excluding West Asia impact) while Q1 is 14.6%.
  • Status:Not yet achieved; guidance lowered/conditioned vs earlier “low-20s” framing.

c. Narrative Shifts

  • From “Hydra supply is the main issue” → “West Asia conflict is the main near-term margin issue.”
  • Earlier calls: Hydra/BIS supply constraints dominated the story.
  • Current call: West Asia fuel/packaging inflation is the dominant explanation for margin decline, even as Hydra remains problematic.
  • More emphasis on energy regulation compliance
  • Solar with battery storage and open access regulations becomes a stronger part of the narrative in Q1 FY27.

d. Consistency & Credibility Signals

  • Medium credibility
  • Strength: management consistently explains price pass-through lag and ties margin to input normalization.
  • Weakness: repeated inability to provide category-wise margin or a quantified ROCE bridge, plus persistent dumping headwind despite prior discussions.
  • No clear pattern of outright contradictions, but precision is limited and timing remains uncertain.

e. Evolution of Key Themes

  • Demand: still framed as resilient; growth continues, but management stresses volume-led rather than price-led.
  • Margins: deterioration in Q1 FY27 attributed to West Asia; earlier calls expected faster margin recovery.
  • Expansion: capex pipeline remains active and detailed (Bharuch, furnace expansion, Hydra lines).
  • Regulatory: BIS/QCO compliance remains a recurring operational driver; now also includes Green Energy Open Access.

f. Additional Insights (cross-period)

  • Inventory as a structural ROCE drag is now explicitly linked to BIS challenges and ramp-up cycles (ROCE weakness explained by inventory build + capex depreciation). This theme is consistent with earlier inventory discussions, but the ROCE target is still not operationalized with a bridge.
  • China dumping remains “sticky”: management previously highlighted dumping as a margin irritant; in Aug 2026 they state it persists despite macro tailwinds, suggesting structural pricing pressure may last longer than hoped.